10 research outputs found

    Influence of spatial arrangement, biofertilizers and bioirrigation on the performance of legume-millet intercropping system in rainfed areas of southern India

    Get PDF
    In this study, we checked the potential of bioirrigation – defined as a process of hydraulic lift where transfer of water occurs from deep soil layers to top soil layers through plant roots. We tested this in a pigeon pea (PP) – finger millet (FM) intercropping system in a field study for two consecutive growing seasons (2016/17 and 2017/18) at two contrasting sites in Bengaluru and Kolli Hills, India. Our objective was also to optimize the spatial arrangement of the intercropped plants (2 PP:8 FM), using either a row-wise or a mosaic design. The field trial results clearly showed that spatial arrangement of component plants affected the yield in an intercropping system. The row-wise intercropping was more effective than mosaic treatments at the Bengaluru field site, while at Kolli Hills, both row-wise and mosaic treatment performed equally. Importantly, biofertilizer application enhanced the yield of intercropping and monoculture treatments. This effect was not influenced by the spatial arrangement of component plants and by the location of the field experiment. The yield advantage in intercropping was mainly due to the release of PP from interspecific competition. Despite a yield increase in intercropping treatments, we did not see a positive effect of intercropping or biofertilizer on water relations of FM, this further explains why PP dominated the competitive interaction, which resulted in yield advantage in intercropping. FM in intercropping had significantly lower leaf water potentials than in monoculture, likely due to strong interspecific competition for soil moisture in intercropping treatments. Our study indicates that identity plant species and spatial arrangement/density of neighbouring plant is essential for designing a bioirrigation based intercropping system

    Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

    Get PDF
    Background Results of small trials indicate that fluoxetine might improve functional outcomes after stroke. The FOCUS trial aimed to provide a precise estimate of these effects. Methods FOCUS was a pragmatic, multicentre, parallel group, double-blind, randomised, placebo-controlled trial done at 103 hospitals in the UK. Patients were eligible if they were aged 18 years or older, had a clinical stroke diagnosis, were enrolled and randomly assigned between 2 days and 15 days after onset, and had focal neurological deficits. Patients were randomly allocated fluoxetine 20 mg or matching placebo orally once daily for 6 months via a web-based system by use of a minimisation algorithm. The primary outcome was functional status, measured with the modified Rankin Scale (mRS), at 6 months. Patients, carers, health-care staff, and the trial team were masked to treatment allocation. Functional status was assessed at 6 months and 12 months after randomisation. Patients were analysed according to their treatment allocation. This trial is registered with the ISRCTN registry, number ISRCTN83290762. Findings Between Sept 10, 2012, and March 31, 2017, 3127 patients were recruited. 1564 patients were allocated fluoxetine and 1563 allocated placebo. mRS data at 6 months were available for 1553 (99·3%) patients in each treatment group. The distribution across mRS categories at 6 months was similar in the fluoxetine and placebo groups (common odds ratio adjusted for minimisation variables 0·951 [95% CI 0·839–1·079]; p=0·439). Patients allocated fluoxetine were less likely than those allocated placebo to develop new depression by 6 months (210 [13·43%] patients vs 269 [17·21%]; difference 3·78% [95% CI 1·26–6·30]; p=0·0033), but they had more bone fractures (45 [2·88%] vs 23 [1·47%]; difference 1·41% [95% CI 0·38–2·43]; p=0·0070). There were no significant differences in any other event at 6 or 12 months. Interpretation Fluoxetine 20 mg given daily for 6 months after acute stroke does not seem to improve functional outcomes. Although the treatment reduced the occurrence of depression, it increased the frequency of bone fractures. These results do not support the routine use of fluoxetine either for the prevention of post-stroke depression or to promote recovery of function. Funding UK Stroke Association and NIHR Health Technology Assessment Programme

    Millet-based intercropping systems facilitated by beneficial microbes for climate-resilient, sustainable farming in tropics

    No full text
    Climate change is arguably the biggest threat being faced by humankind, one that impacts billions of people through soil erosion, extreme droughts, uneven and unpredictable rains during the cropping season, rises in sea level, etc. Climate-induced droughts limit crop growth and productivity, eventually affecting millions of marginal farmers. Millets are predominantly grown in rainfed and arid regions, especially in the tropical zones of Asia and Africa. They are rich in macro and micronutrients that can complement other sources of nutrition such as cereals, vegetables, fruits, milk, meat and eggs. Millet-based intercropping systems have been practiced in India over centuries. Nevertheless, a sustainable intensification of millet-based intercropping has not yet been achieved. Recent research findings have shown that millet and legume intercropping facilitated by biofertilizers, such as arbuscular mycorrhizal fungi and plant-growth-promoting rhizobacteria, is a promising innovative tool. This chapter aims at exploring research and development perspectives for promoting millet-based intercropping systems for sustainable farming, particularly in the tropics

    Spatial Arrangement and Biofertilizers Enhance the Performance of Legume - Millet Intercropping System in Rainfed Areas of Southern India

    Get PDF
    Intercropping is a well-established practice to enhance the yield in low-input agriculture, and beneficial microbes such as arbuscular mycorrhizal fungi (AMF) combined with plant growth promoting rhizobacteria are being used as an effective and sustainable measure to improve yields. In this study, we tested if biofertilizers can not only enhance the yield of crops in monoculture as has previously been demonstrated but can also enhance the yield of intercropping systems. We hypothesized that because AMF can form common mycorrhizal networks (CMN) that can transfer nutrients and water between different plant species, biofertilization can balance belowground competition between crop species and promote thus overall yields in intercropping systems. In our study, we used a pigeon pea (PP)—finger millet (FM) intercropping system that we grew for two consecutive growing seasons (2016/17 and 2017/18) at two contrasting sites in Bengaluru and Kolli Hills, India. We also tested if the spatial arrangement (i.e., different arrangement of component plants with similar plant density in intercropping system) of intercropped plants, using either a row-wise or a mosaic design, influences the effect of biofertilizers on yield and water relations of the PP-FM intercropping system. Our results demonstrate that intercropping can improve the straw and grain yield of PP and FM compared to the respective monocultures and that intercropping effects vary depending on the site characteristic such as climate and soil type. The spatial arrangement of component plants affected the total, straw, and grain biomass in intercropping treatments, but this effect also varied across sites. Most importantly, the results from the 2017/18 growing season clearly demonstrated a positive effect of biofertilizer on biomass yield, and this effect was irrespective of site, spatial arrangement, mixed or monoculture. Our study therefore shows that yield increase in intercropping systems can further be improved through the application of biofertilizers

    Feasibility of reporting results of large randomised controlled trials to participants:experience from the Fluoxetine or Control under supervision (FOCUS) trial

    No full text
    Objectives Informing research participants of the results of studies in which they took part is viewed as an ethical imperative. However, there is little guidance in the literature about how to do this. The Fluoxetine Or Control Under Supervision trial randomised 3127 patients with a recent acute stroke to 6 months of fluoxetine or placebo and was published in the Lancet on 5 December 2018. The trial team decided to inform the participants of the results at exactly the same time as the Lancet publication, and also whether they had been allocated fluoxetine or placebo. In this report, we describe how we informed participants of the results.Design In the 6-month and 12-month follow-up questionnaires, we invited participants to provide an email address if they wished to be informed of the results of the trial. We re-opened our trial telephone helpline between 5 December 2018 and 31 March 2019.Setting UK stroke services.Participants 3127 participants were randomised. 2847 returned 6-month follow-up forms and 2703 returned 12-month follow-up forms; the remaining participants had died (380), withdrawn consent or did not respond.Results Of those returning follow-up questionnaires, a total of 1845 email addresses were provided and a further 50 people requested results to be sent by post. Results were sent to all email and postal addresses provided; 309 emails were returned unrecognised. Seventeen people replied, of whom three called the helpline and the rest responded by email.Conclusion It is feasible to disseminate results of large trials to research participants, though only around 60% of those randomised wanted to receive the results. The system we developed was efficient and required very little resource, and could be replicated by trialists in the future.Trial registration number ISRCTN83290762; Post-results
    corecore